F. A. Klok
Leiden University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name F. A. Klok as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:39 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06833827 · 'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NLLeiden University Medical Center · recruiting · Pulmonary Embolism Acute · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:39 UTC. The ranking covers the 200 most relevant of 33 PubMed records, and a shared surname and initials can bring in a namesake. All 33 on PubMed
- 411 citationsRCR 19.0
- 247 citationsRCR 13.5
- Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment.Eur Respir J · 2016204 citationsRCR 8.2
- Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.N Engl J Med · 2025137 citationsRCR 40.4
- Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial.Eur Heart J · 2021130 citationsRCR 9.8
- Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.Am J Respir Crit Care Med · 2016119 citationsRCR 5.3
- External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.Thromb Haemost · 201775 citationsRCR 3.1
- Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score.Thromb Haemost · 202267 citationsRCR 5.7
- Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.Eur Respir J · 201860 citationsRCR 2.8
- Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.Clin Res Cardiol · 201959 citationsRCR 3.4